{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:48Z","timestamp":1786123248381,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1213\/ane.0b013e3181b366c4","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T03:16:20Z","timestamp":1253070980000},"page":"1346-1347","source":"Crossref","is-referenced-by-count":4,"title":["Hydroxyethyl Starch 130\/0.4: Does \u201cModern\u201d Mean Safe?"],"prefix":"10.1213","volume":"109","author":[{"given":"Christian J.","family":"Wiedermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-57-20210902","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1213\/ane.0b013e31819e9e6c","article-title":"Modern rapidly degradable hydroxyethyl starches: current concepts.","volume":"108","author":"Boldt","year":"2009","journal-title":"Anesth Analg"},{"key":"R2-57-20210902","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00134-008-1225-2","article-title":"The risk associated with hyperoncotic colloids in patients with shock.","volume":"34","author":"Schortgen","year":"2008","journal-title":"Intensive Care Med"},{"key":"R4-57-20210902","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/bja\/aen001","article-title":"Comparison of the novel hydroxyethylstarch 130\/0.4 and hydroxyethylstarch 200\/0.6 in brain-dead donor resuscitation on renal function after transplantation.","volume":"100","author":"Blasco","year":"2008","journal-title":"Br J Anaesth"},{"key":"R5-57-20210902","first-page":"A1514","article-title":"Hydroxyethylstarch increases the risk for acute renal failure in patients with severe ARDS.","volume":"107","author":"Briegel","year":"2007","journal-title":"Anesthesiology"},{"key":"R6-57-20210902","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ane.0b013e31818c1282","article-title":"Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.","volume":"108","author":"Schramko","year":"2009","journal-title":"Anesth Analg"},{"key":"R7-57-20210902","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00044011-199816020-00008","article-title":"Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130\/0.4)] after single-dose infusion of 6% or 10% solutions in healthy volunteers.","volume":"16","author":"Waitzinger","year":"1998","journal-title":"Clin Drug Invest"},{"key":"R8-57-20210902","first-page":"255","article-title":"A clinical physiologic study of hydroxyethyl starch.","volume":"131","author":"Metcalf","year":"1970","journal-title":"Surg Gynecol Obstet"},{"key":"R9-57-20210902","first-page":"304","article-title":"HAES in der Sepsis: ein Damoklesschwert?","volume":"9","author":"Hagne","year":"2009","journal-title":"Schweiz Med Forum"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ane.0b013e3181b366c4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:12:53Z","timestamp":1786111973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200910000-00057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181b366c4","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}